10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2018 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 13, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Cash flows from operating activities: | |||
| Net income | $ 8,394 | 1,979 | 7,722 |
| Depreciation and amortization | 1,946 | 1,955 | 2,105 |
| Stock-based compensation expense | 311 | 329 | 311 |
| Deferred income taxes | (363) | (1,330) | 183 |
| Other items, net | 386 | 334 | 32 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (378) | (58) | (214) |
| Inventories | (3) | 133 | (80) |
| Other assets | 35 | (24) | (128) |
| Accounts payable | (143) | 424 | (44) |
| Accrued income taxes, net | (361) | 523 | (301) |
| Long-term tax liabilities | 258 | 6,681 | 445 |
| Other liabilities | 1,214 | 231 | 323 |
| Net cash provided by operating activities | 11,296 | 11,177 | 10,354 |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (18,741) | (33,607) | (28,094) |
| Proceeds from sales of marketable securities | 28,356 | 24,240 | 17,958 |
| Proceeds from maturities of marketable securities | 5,412 | 6,174 | 2,459 |
| Purchases of property, plant and equipment | (738) | (664) | (738) |
| Cash acquired in acquisition, net of cash paid | 195 | (19) | 0 |
| Other | (145) | (148) | (243) |
| Net cash provided by (used in) investing activities | 14,339 | (4,024) | (8,658) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 0 | 4,476 | 7,318 |
| Repayment of debt | (1,121) | (4,405) | (3,725) |
| Repurchases of common stock | (17,794) | (3,160) | (2,965) |
| Dividends paid | (3,507) | (3,365) | (2,998) |
| Withholding taxes arising from shares withheld for share-based payments | (126) | (191) | (260) |
| Other | 58 | 51 | 31 |
| Net cash used in financing activities | (22,490) | (6,594) | (2,599) |
| Increase (decrease) in cash and cash equivalents | 3,145 | 559 | (903) |
| Cash and cash equivalents at beginning of year | 3,800 | 3,241 | |
| Cash and cash equivalents at end of year | 6,945 | 3,800 | 3,241 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |